Others

Since 1993, Sompo Asset Management has launched initiatives that incorporate ESG elements into investment value analysis, and has actively developed asset management products that place further emphasis on an ESG perspective. Among these, the “Buna no Mori” fund, which was launched in 1999, is one of the company’s leading funds, and has paved the way for ESG investment within Japan. Going forward, Sompo Asset Management will work on promoting ESG investments by steadily advancing such initiatives.

Sompo Health Support has developed “Mykinso Hana,” a new intestinal flora test and self-care program that encourages behavioral change by providing advice on improving lifestyle and dietary habits tailored to each of five types of intestinal environments classified based on their similarity.
The product is based on joint research on the relationship between intestinal flora and hay fever with Cykinso, Inc., a company with a proven track record in intestinal flora testing.
Intestinal flora tests were carried out on 282 Sompo Group employees to see if conditions such as allergies that affect “presenteeism” (employees reporting to work despite being ill and working while physically unwell) could be alleviated by improving the intestinal environment. By scoring the severity of hay fever symptoms and conducting questionnaires on lifestyle habits, the study revealed lifestyle patterns that contribute to hay fever symptoms.
“Mykinso Hana” is available to medical insurers, businesses, organizations, and their members. It is used by companies to promote health and productivity management that encourages awareness of conditions affecting presenteeism, by various organizations to improve services for their members, and by medical insurers to reduce medical costs.